Header Logo

Connection

Philip Comp to Recombinant Proteins

This is a "connection" page, showing publications Philip Comp has written about Recombinant Proteins.
Connection Strength

0.110
  1. Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
    View in: PubMed
    Score: 0.056
  2. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993 Feb 01; 81(3):734-44.
    View in: PubMed
    Score: 0.024
  3. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care. 2004 Apr; 8(2):R82-90.
    View in: PubMed
    Score: 0.013
  4. Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. J Rheumatol. 2000 Feb; 27(2):384-90.
    View in: PubMed
    Score: 0.010
  5. Cytokine-induced alteration of platelet and hemostatic function. Stem Cells. 1996; 14 Suppl 1:154-62.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.